lobbying_activities: 3436213

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3436213	3006f347-2888-4478-8ce3-2bf5343b2ffe	Q3	INDEPENDENT PHARMACY COOPERATIVE	313098	INDEPENDENT PHARMACY COOPERATIVE	2025	third_quarter	PHA	IPC supports Protecting Pharmacies in Medicaid Act (S.927). IPC supports PBM Reform Act of 2025 (HR 4317). IPC supports Patients Before Middlemen Act (S 882). IPC supports The Ensuring Community Access to Pharmacist Services Act of 2025 (ECAPS). CMS Implementation of drug provisions of the IRA 2022-including the drug negotiation provision with changes and prescription drug co-pay spread option. IPC supports the removal of the mandatory NADAC reporting requirement in the OBBB without an adequate and defined corresponding professional dispensing fee. IPC supports the Rural Health Transformation Program.	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE		40000	0	0	2025-10-16T11:21:38-04:00